Authors' contributions
Chris Bojke has been trial economist since 2005. He contributed to the management, validation, analysis and interpretation of data, and writing this paper. He serves as the corresponding author for this paper following its publication.
Ian Wong was grantholder and chief investigator responsible for the pharmacy component of the trial. He contributed to the original grant application, and the design, implementation and management of the trial. He guarantees the clinical content of this paper. All authors commented on successive drafts of this paper, and can defend its content.
Mark Sculpher was principal investigator responsible for economic evaluation. He contributed to the economic protocol, interpreting data and writing this paper. He guarantees its economic content.
Ian Russell was grantholder and principal investigator responsible for trial methods. He contributed to the original grant application, the design and implementation of the trial, the economic protocol, interpreting data, and writing this paper.
Stewart Richmond was trial manager, responsible for overall management and quality assurance. He contributed to the design, implementation, and management of the trial, developing procedures and data collection instruments, the design, implementation, and management of the recruitment and data collection plan, analysing and interpreting data, and writing this paper. He served as the corresponding author for this paper prior to its publication.
Zoë Philips was trial economist, responsible for designing and implementing the economic evaluation plan. She contributed to designing, implementing, and managing the trial, developing procedures and data collection instruments, and collecting, managing, analysing, and interpreting data. She prepared the initial draft of this paper.
Veronica Morton was trial statistician from December 2004, responsible for developing and implementing the statistical analysis plan, and validating data statistically. She contributed to the design, implementing and managing the trial, and managing, analysing, and interpreting data.
Jeremy Miles was trial psychometrician responsible for the validity and reliability of questionnaires and data collection instruments. He contributed to the design and implementation of the trial, and the analysis and interpretation of data.
Graham Hill was pharmacy practice adviser. He contributed to the design, implementation, and management of pharmaceutical care.
Andrea Hilton was trial pharmacist, responsible for implementing and managing the introduction of, and training for, pharmaceutical care. She contributed to the design, implementation, and management of the trial, the anglicisation of the UK-MAI, developing and implementing procedures and data collection instruments.
Amanda Farrin was trial statistician until November 2004 and statistical adviser thereafter. She contributed to the design and implementation of the trial, developing data collection procedures and instruments, the statistical analysis plan, and the interpretation of results.
Ben Cross was assistant trial data manager. He contributed to database design and management.
Simon Coulton was trial data manager, responsible for database design and management. He contributed to the design and implementation of the trial, and developing questionnaires and data collection instruments.
Henry Chrystyn was academic pharmacy adviser. He contributed to the design, implementation and management of both the introduction of pharmaceutical care and the trial.
Peter Campion was grantholder and principal investigator responsible for recruitment and training in primary care. He contributed to the original grant application, and the design, implementation and management of the trial.
